Drug Launch Strategy Analysis: Success Story of Identifying First Launch, Timelines, and Geographies Through Primary Intelligence
A Germany-based mid-sized pharma company actively engaged in the late-stage development of a therapy for Primary Immunodeficiency (PID) and, with a strong marketing... Read more.
BAVENCIO Continues to Strengthen Its Position in the Immuno-Oncology Landscape | DelveInsight
With the rising adoption of checkpoint inhibitors and combination therapies, BAVENCIO’s market growth is driven by expanding indications and strategic partnerships.... Read more.
Broadway Financial Corporation Announces New Board Member
LOS ANGELES, March 10, 2025 /PRNewswire/ — Broadway Financial Corporation (“Broadway” or the “Company”) (NASDAQ: BYFC), parent company... Read more.
HealthTree Foundation Launches New Mobile App to Empower Blood Cancer Patients
HealthTree App Offers Patient Support, Education, and Research Participation in One Seamless Platform SALT LAKE CITY, March 10, 2025 /PRNewswire/ — HealthTree... Read more.
Azenta to Participate in the Virtual KeyBanc Capital Markets Healthcare Forum
BURLINGTON, Mass., March 10, 2025 /PRNewswire/ — Azenta, Inc. (Nasdaq: AZTA) announced that Lawrence Y. Lin, Executive Vice President and Chief Financial Officer,... Read more.
Yalla Group Limited Announces Unaudited Fourth Quarter and Full Year 2024 Financial Results
DUBAI, UAE, March 10, 2025 /PRNewswire/ — Yalla Group Limited (“Yalla” or the “Company”) (NYSE: YALA), the largest Middle East and... Read more.
Pascal Desroches to Update Shareholders at Deutsche Bank Media, Internet & Telecom Conference on March 11
DALLAS, March 10, 2025 /PRNewswire/ — Tomorrow, AT&T’s chief financial officer will participate in a fireside chat where he will discuss the Company’s... Read more.
Kodiak Sciences Completes Enrollment in Second Registrational Trial of Tarcocimab in Patients with Diabetic Retinopathy
Topline clinical data of the confirmatory registrational study GLOW2 expected in 1Q 2026. GLOW2 study design mirrors GLOW1 study, which met primary endpoint and... Read more.
Join Fathom Holdings’ Exclusive Live Investor Webinar and Q&A Session on March 13
CARY, N.C., March 10, 2025 /PRNewswire/ — Fathom Holdings, Inc. (Nasdaq: FTHM) (“Fathom”; or the “Company“), a national, technology-driven,... Read more.
Canaan Inc. Enters into Securities Purchase Agreement for Series A-1 Preferred Shares Financing and Completes First Tranche Closing
Provides Company with access to up to US$200 million SINGAPORE, March 10, 2025 /PRNewswire/ — Canaan Inc. (NASDAQ: CAN) (“Canaan” or the “Company”),... Read more.